Health
Metformin use reduces risk of death for patients with Covid-19, diabetes – Hindustan Times
Use of the diabetes drug metformin, before a diagnosis of Covid-19 is associated with a threefold decrease in mortality in Covid-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of Covid-19 is associated with a threefold decrease in mortality in Covid-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham.
Diabetes is a significant comorbidity for Covid-19.
“This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive…
-
General22 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Noosa News23 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General14 hours agoPope Francis makes surprise first appearance after hospital stay
-
Noosa News6 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots